Live from the NIH registry
Studies recruiting near Columbus right now
Top 25 of 67 recruiting studies, sorted by proximity — each links to its official registry page
Registry for Stage 2 Type 1 Diabetes
Type 1 Diabetes
N/A
Observational 200 participants sought
Midtown Medical Center - Columbus- Site Number : 8400013 — Columbus, Georgia (7.3 mi)
· Sponsor: Sanofi
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Phase 1, Phase 2
Interventional 500 participants sought
Local Institution - 2134 — Columbus, Georgia (7.3 mi)
· Sponsor: Turning Point Therapeutics, Inc.
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Local Institution - 0016 — Columbus, Georgia (7.3 mi)
· Sponsor: Bristol-Myers Squibb
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
Endometriosis
N/A
Observational 1,200 participants sought
Midtown OBGYN North — Columbus, Georgia (7.3 mi)
· Sponsor: Aspira Women's Health
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Centricity Research - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: vTv Therapeutics
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
DCR Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Takeda
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
Diabetic Foot Ulcer, Foot Ulcer
Phase 3
Interventional 230 participants sought
IACT Health — Columbus, Georgia (7.3 mi)
· Sponsor: Energenesis Biomedical Co., Ltd.
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Asthma
N/A
Observational 2,500 participants sought
The Allergy Center at Brookstone - Site Number: 840114 — Columbus, Georgia (7.3 mi)
· Sponsor: Sanofi
A Study to Assess Growth in Children With Idiopathic Short Stature
Idiopathic Short Stature
N/A
Observational 300 participants sought
Centricity Research — Columbus, Georgia (7.3 mi)
· Sponsor: BioMarin Pharmaceutical
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Centricity Research - Endocrine Consultants Research /ID# 255738 — Columbus, Georgia (7.3 mi)
· Sponsor: AbbVie
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Obesity or Overweight, Type 2 Diabetes Mellitus
Phase 3
Interventional 1,600 participants sought
Centricity Research Columbus Georgia Multispecialty — Columbus, Georgia (7.3 mi)
· Sponsor: Hoffmann-La Roche
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Columbus, Georgia (7.3 mi)
· Sponsor: Alnylam Pharmaceuticals
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Colorectal Cancer, Sarcopenia
N/A
Observational 300 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Wake Forest University Health Sciences
An Internet-based Program to Help Cancer Survivors Manage Pain
Cancer
N/A
Interventional 456 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Wake Forest University Health Sciences
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Contraception
N/A
Interventional 573 participants sought
Midtown OB GYN North — Columbus, Georgia (7.3 mi)
· Sponsor: Femasys Inc.
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
Centricity Research Columbus Dermatology — Columbus, Georgia (7.3 mi)
· Sponsor: Celldex Therapeutics
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Phase 3
Interventional 444 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Bayer
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 210 participants sought
Site Number - 1020 — Columbus, Georgia (7.3 mi)
· Sponsor: Immunovant Sciences GmbH
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Non-small Cell Lung Cancer, NSCLC
Phase 3
Interventional 851 participants sought
Centricity Research Columbus Cancer Center ( Site 0111) — Columbus, Georgia (7.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Phase 2, Phase 3
Interventional 176 participants sought
DaVita Clinical Research Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Cardiotoxicity, HER2/Neu Positive
Phase 3
Interventional 491 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Clostridioides Difficile Associated Disease
Phase 3
Interventional 32,000 participants sought
Centricity Research Columbus Georgia Multispecialty — Columbus, Georgia (7.3 mi)
· Sponsor: Pfizer
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Phase 3
Interventional 780 participants sought
Centricity Research Columbus Cancer Center ( Site 0005) — Columbus, Georgia (7.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Regeneron Pharmaceuticals